CBRS now carries four of five desk bells after its Q2 print while the July post-flush confirmation above 221.30 remains cleared. This is a deep-dive refresh trigger, not a fresh entry: the board marks the move as already extended through the trigger.

ABCL reclaimed its 52-week-high line and converted to a paper conviction unit; DUK lost its 200-day and the power-squeeze defensive leg is invalidated

The July 19 money-loop desk call on ELAN hit its written invalidation: the stock closed $22.12 on 2026-08-07, under the $23.68 trigger, after an -8.6% single-day drop on its Aug 5 earnings print — a print for which no results coverage exists in the corpus. The call is invalidated on its own terms; the animal-health demand thesis question stays open pending the missing Q2 read.

The volatility complex disarmed in one session: VIXY closed down 12.25% over seven days, tripping the midterm-window fear-disarms trigger, while the desk's volatility gauges flipped to calm and vol-compressed the same evening. Fear leaving a consolidating tape reads two ways — a turn-tell arming, or melt-up complacency — and the deciding evidence is still missing.

Three tracked entry conditions crossed on the same session — Teradyne reclaimed its 50-day at 403.56 on a +10.3% post-print day, Cerebras closed above its 221.30 post-flush confirmation, and the SK hynix ADR crossed its 151.05 trigger on a low-volume pop that leaves the base unproven. Convergence alarms raised NVDA to four bells and lit ARM, NBIS, CBRS, SKHY, and TER at three. The Teradyne condition was judged fully met; SK hynix crossing judged provisional until the level holds. Watch whether tonight AMD and Arista prints extend or break the cluster.

First confirmed index strength for the midterm-window thesis: SPY momentum recovered with a positive month on the same session the breadth gauge flipped to broad strength. Consistent with the turn the perspective watches for — not yet confirmation; the next dominoes are small-caps leading and the fear gauges disarming.

Three risk-off gauge transitions in one session (defensive metal ratio, breadth short-term fragile, VIX elevated) plus two machine-verified invalidation legs: MU through 804, WULF through 15.67 — the derate is broadening while fundamentals print records

Both the July 18 semiconductor turn-signature call and the July 8 washout-slate KGS leg closed below their written invalidation levels on Tuesday's tape

The most-active congressional filers accumulated semis, memory, and optical names through May-June; disclosed buys cluster on the same complexes the desk already tracks as supply-chain tightness lanes.

Five independently-watched accounts converged on the robotics/physical-AI rotation inside ~2 weeks — a crowding / late-distribution tell for a theme the book is already positioned in (VPG, OUST tracked/held), not a fresh entry. Corroborated by the sector tape: Technology (largest bucket) rolling over on the 7D window while defensives and energy rotate in.

Single-name dispersion is elevated: mega-cap median |weekly move| >= 2.2% (13wk window) while the index stays calm — stock-picking weather where fixed-percent thresholds dilute; read pullback/drawdown lines against the climate gauge, not 2010s physics

A ≥30% single-day VIX jump is a marketwide fire-sale trigger to tighten up and build a shopping list — the forward edge shows up about one month out (positive 21 of 23 times in a 2016–2026 backtest) not same-day where 1-day/1-week returns are a coin flip

VIXY decayed 40%+ from 52-week high + SPY at/near ATH + realized vol on SPY < 12 (annualized) → low-vol regime in force. The vol structure is so suppressed that any single risk-off catalyst would mean-revert violently — corroborates bufr-cap-saturation from a vol-product mechanism rather than a buffered-ETF mechanism.

VTV/VUG ratio at multi-month low while value-cohort scans (defensive, consumer-staples) print cold and growth-cohort (mag7, ai-infra, semis) prints hot — confirms a value-lagging / growth-leading regime, not a rotation in progress.

Buffered ETFs pinning their upside caps (BUFR/BAPR/BJAN at ATH + RSI 70+) tell that the market is in a low-vol melt-up regime — the math only works when the underlying grinds higher without realized vol spikes.

The memory-supercycle lane's #1 fundamental risk is a supply glut — the oligopoly (Samsung/SK Hynix/Micron in DRAM; +Kioxia/SanDisk in NAND) ramping capex into the tightness until new volume overshoots demand. Every memory cycle ends this way. This signal stays DORMANT while supply is short and contract prices accelerate; it FIRES (lane shifts from bull to caution/trim) when the precursors below appear. It is a thesis-gate, not a trade trigger.

The biotech funding/capital-markets gate is the master switch for the biotech-capital-cycle thesis: the whole AI-bio/tools/CRO complex sells to biotech, so it re-rates when biotech FUNDING returns. As of 2026-06-04 the gate is HALF-OPEN — the ISSUANCE leg is firing (a live 2026 IPO wave: Kailera $625M record, Generate/GENB $400M, Eikon $381M, Aktis $318M, Alamar $220M) but the EQUITY-APPETITE leg is NOT (XBI weak-down RSI 45 below SMA20; GENB & Eikon fell on debut; strength is narrow/genomics-only via ARKG). Capital is being RAISED but the market isn't paying up for it yet. The signal FIRES when the appetite leg confirms — that's the trigger that flips the lane from "wait / hold mega-cap-quality laggards" to "rotate into the laggards before they catch up." Disciplined nuance: even half-open, the issuance leg already feeds the FUNDAMENTAL dominoes (biotechs spend raised cash on reagents/CROs/instruments regardless of where their own equity trades), so the picks-and-shovels case strengthens ahead of the formal fire.